A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

A NEW Phase 3 trial has shown that a combination therapy of cagrilintide and semaglutide (CagriSema) can lead to substantial ...

Delhi High Court on Wednesday asked Drug Controller General of India (DCGI) to consult experts and relevant stakeholders ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

Patients with only dry eye had less severe lid margin abnormalities and orifice plugging along with tear film instability ...

In its order, CJ Upadhyaya-led bench directed PIL litigant to submit to CDSCO the scientific studies and data relied upon in ...

After a one-year follow-up, 10 of 12 patients given the islet cell therapy zimislecel no longer required insulin. Vertex ...

New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in ...

Indian astronaut Shubhanshu Shukla’s Ax-4 mission aboard the ISS is studying how microgravity affects glucose metabolism. The ...

From cancer immunotherapy to diabetes and weight loss breakthroughs, 2025’s top-selling drugs highlight how pharmaceutical ...

The British drug agency is monitoring a possible increase in cases of the disease, although there is no data yet to warrant ...